WallStreetZenWallStreetZen

NASDAQ: SNGX
Soligenix Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Soligenix revenue was $119.37k for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SNGX annual revenue was $119.4k, with -85.8% growth year-over-year.

SNGX past revenue growth

How has SNGX's revenue growth performed historically?

Company
-85.78%
Industry
497.69%
Market
20.68%
SNGX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SNGX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SNGX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SNGX revenue history

Current Revenue
$119.4k
Current Earnings
-$8.3M
Current Profit Margin
-6,925.1%

Be the first to know when SNGX announces revenue.

SNGX Revenue History By Year

SNGX Yearly RevenueSNGX RevenueSNGX ChangeSNGX Revenue Growth
2024-12-31$119.37k-$719.99k-85.78%
2023-12-31$839.36k-$109.55k-11.55%
2022-12-31$948.91k$124.64k+15.12%
2021-12-31$824.27k-$1.54M-65.07%
2020-12-31$2.36M-$2.27M-49.04%
2019-12-31$4.63M-$611.53k-11.67%
2018-12-31$5.24M-$191.02k-3.52%
2017-12-31$5.43M-$5.02M-48.01%
2016-12-31$10.45M$1.68M+19.16%
2015-12-31$8.77M$1.73M+24.50%
2014-12-31$7.04M$3.82M+118.45%
2013-12-31$3.22M$79.53k+2.53%
2012-12-31$3.14M-$4.52M-58.96%
2011-12-31$7.66M$5.72M+293.44%
2010-12-31$1.95M-$868.41k-30.84%
2009-12-31$2.82M$505.77k+21.89%
2008-12-31$2.31M$1.05M+83.64%
2007-12-31$1.26M-$1.06M-45.61%
2006-12-31$2.31M-$762.72k-24.80%
2005-12-31$3.08M$2.08M+208.35%
2004-12-31$997.48k$913.67k+1,090.07%
2003-12-31$83.82kN/AN/A
2002-12-31$0.00N/AN/A
2001-12-31$0.00N/AN/A
2000-12-31$0.00N/AN/A
1999-12-31$0.00N/AN/A
1998-12-31$0.00N/AN/A
1997-12-31$0.00N/AN/A
1996-12-31$0.00N/AN/A

1 of 2

Soligenix Revenue FAQ

What was SNGX's revenue last quarter?

On Invalid Date, Soligenix (NASDAQ: SNGX) reported Q4 2024 revenue of $0.00 up 100% year over year. In the same quarter last year, Soligenix's revenue was $244.81 thousand.

What was Soligenix's revenue in 2024?

Soligenix's annual revenue for the twelve months ending Dec 31, 2024 was $119.37 thousand, a 85.78% decrease year over year.

How much does Soligenix make in a day?

Based on Soligenix annual revenue for the past five years, SNGX makes an average of $2,789.78 per day.

What was Soligenix's annual revenue growth in the past year?

As of Q2 2025, Soligenix's revenue has grown -85.78% year over year. This is 583.47 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Soligenix's revenue in the past year totaled $119.37 thousand.

How much does Soligenix make in a year?

Soligenix's revenue by year for the past five years is:
  • Soligenix's revenue for the twelve months ending Dec 31, 2024 was $119.37 thousand, a 85.78% decrease year over year.
  • Soligenix's annual revenue for Dec 31, 2023 was $839.36 thousand, a 11.55% decrease from 2022.
  • Soligenix's annual revenue for 2022 was $948.91 thousand, a 15.12% increase from 2021.
  • Soligenix's annual revenue for 2021 was $824.27 thousand, a 65.07% decrease from 2020.
  • Soligenix's annual revenue for 2020 was $2.36 million, a 49.04% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.